This inventor holds 2 USPTO granted patents. Top assignee: National Research Development Corporation. Active years: 1987-1991.
Company Filing History:
Years Active: 1987-1991
Title: Allan B Foster: Innovator in Pharmaceutical Chemistry
Introduction
Allan B Foster is a notable inventor based in Carshalton Beeches, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating oestrogen-dependent tumors. With a total of 2 patents, his work has the potential to impact therapeutic strategies in oncology.
Latest Patents
Foster's latest patents include innovative compounds such as 2,6-dioxopiperidine derivatives and glutarimide derivatives. These compounds are designed to enhance the efficacy of existing treatments for oestrogen-dependent tumors. Specifically, his research has focused on improving the therapy obtainable from the compound aminoglutethimide. The glutarimide derivatives he has developed feature a unique formula that includes 3-ethyl-3-(4-pyridyl)glutarimide, which has shown promise in this therapeutic area.
Career Highlights
Throughout his career, Allan B Foster has been associated with the National Research Development Corporation. His work has been instrumental in advancing pharmaceutical research and development, particularly in the context of cancer treatment. His innovative approach to drug formulation has garnered attention in the scientific community.
Collaborations
Foster has collaborated with esteemed colleagues such as Michael Jarman and Chui-Sheung Kwan. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his research.
Conclusion
Allan B Foster's contributions to pharmaceutical chemistry, particularly in the development of treatments for oestrogen-dependent tumors, highlight his role as an influential inventor. His innovative patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.